NO991908L

Immune response modifier compounds for treatment of th2 mediated and related diseases

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed and published
  3. Today

36 members in 16 offices

This recordMember, by publication datePriority claim6 more offices are in the list below

Priority claims12

Priority claims
DocumentOfficeKindDate
2930196United States of AmericaP
2930196United States of AmericaP
4533197United States of AmericaP
4533197United States of AmericaP
9719990United States of AmericaW
9719990United States of AmericaW
2930196
4533197
9719990
US19960029301P
US19970045331P
WO1997US19990

Members36

Family members, oldest first
DocumentOfficeKind
CA2268957A1CanadaA1
WO9817279A1World Intellectual Property Organization (WIPO)A1
AU5164198AAustraliaA
NO991908D0NorwayD0
NO991908LThis recordNorwayL
EP0938315A1European Patent Office (EPO)A1
IL129319D0IsraelD0
US6039969AUnited States of AmericaA
HU9904665A2HungaryA2
HUP9904665A2HungaryA2
HK1022422A1Hong Kong, ChinaA1
KR20000052657ARepublic of KoreaA
AU724042B2AustraliaB2
CZ9901420A3CzechiaA3
HU9904665A3HungaryA3
HUP9904665A3HungaryA3
NZ335124ANew ZealandA
JP2001502699AJapanA
US6200592B1United States of AmericaB1
US2002041887A1United States of AmericaA1
US6610319B2United States of AmericaB2
US2003206868A1United States of AmericaA1
US6696076B2United States of AmericaB2
US2004242620A1United States of AmericaA1
CZ294563B6CzechiaB6
KR100518903B1Republic of KoreaB1
IL129319AIsraelA
EP0938315B1European Patent Office (EPO)B1
AT367159TAustriaT
ATE367159T1AustriaT1
DE69737935D1GermanyD1
ES2290969T3SpainT3
EP0938315B9European Patent Office (EPO)B9
DE69737935T2GermanyT2
CA2268957CCanadaC
JP4391592B2JapanB2